-+ 0.00%
-+ 0.00%
-+ 0.00%

EQL Pharma Enters UTI Treatment License Deal in Hungary

MT Newswires·08/12/2026 05:25:20
Listen to the news
05:25 AM EDT, 08/12/2026 (MT Newswires) -- EQL Pharma (EQL.ST) entered a deal with fellow pharmaceutical company Pharmacenter to bring its recurring urinary tract infection treatment, Memprex, to Hungary. The company said Wednesday that the agreement will grant Pharmacenter the exclusive rights for Memprex in exchange for a five-figure euro payment that will be paid over three milestones, subject to an agreed-upon sales target.